Phase I/II study of docetaxel (D), gemcitabine (G), and bevacizumab (B) in patients (pts) with advanced or recurrent soft tissue sarcoma (STS) ...
Prognostic factors associated with distant recurrence in patients with intimal sarcoma at a tertiary sarcoma referral center in Latin America. This is an ASCO Meeting Abstract from the 2025 ASCO ...
In this retrospective analysis, outcomes data were evaluated on patients receiving care related to extrapleural pneumonectomy for soft tissue sarcoma or bone sarcoma. “Patient selection is critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback